PDB Short entry for 1FGD HEADER BLOOD COAGULATION INHIBITOR 28-NOV-95 1FGD TITLE EPIDERMAL GROWTH FACTOR (EGF) SUBDOMAIN OF HUMAN THROMBOMODULIN (NMR, TITLE 2 11 STRUCTURES) COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBOMODULIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL SUBDOMAIN, RESIDUES 409 - 426, OF 5TH EPIDERMAL COMPND 5 GROWTH FACTOR (EGF); COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS BLOOD COAGULATION INHIBITOR, THROMBOMODULIN, EGF EXPDTA SOLUTION NMR NUMMDL 11 AUTHOR R.HRABAL,E.A.KOMIVES,F.NI REVDAT 3 23-FEB-22 1FGD 1 REMARK REVDAT 2 24-FEB-09 1FGD 1 VERSN REVDAT 1 20-JUN-96 1FGD 0 JRNL AUTH R.HRABAL,E.A.KOMIVES,F.NI JRNL TITL STRUCTURAL RESILIENCY OF AN EGF-LIKE SUBDOMAIN BOUND TO ITS JRNL TITL 2 TARGET PROTEIN, THROMBIN. JRNL REF PROTEIN SCI. V. 5 195 1996 JRNL REFN ISSN 0961-8368 JRNL PMID 8745396 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FGD COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173274. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 11 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 417 -87.25 56.80 REMARK 500 1 PHE A 419 64.97 70.51 REMARK 500 1 ILE A 424 -50.08 -174.78 REMARK 500 2 PHE A 419 66.86 68.15 REMARK 500 2 ASP A 423 -173.80 -63.32 REMARK 500 3 PRO A 410 -168.97 -75.68 REMARK 500 3 PHE A 419 71.41 68.43 REMARK 500 4 PHE A 419 71.44 66.44 REMARK 500 4 ASP A 423 -171.57 -68.57 REMARK 500 4 ILE A 424 -139.03 -115.84 REMARK 500 4 ASP A 425 83.00 64.16 REMARK 500 5 PHE A 419 69.21 68.26 REMARK 500 6 ASP A 417 -94.79 49.63 REMARK 500 6 PHE A 419 69.50 72.42 REMARK 500 6 ASP A 423 -172.92 -68.67 REMARK 500 7 PHE A 419 70.07 66.89 REMARK 500 8 PHE A 419 60.64 61.05 REMARK 500 8 ASP A 423 -172.52 -65.76 REMARK 500 9 ASP A 417 -90.79 54.94 REMARK 500 9 PHE A 419 67.30 70.65 REMARK 500 9 ILE A 424 -147.46 -121.38 REMARK 500 10 PRO A 410 -167.80 -77.14 REMARK 500 10 ASP A 417 -96.65 51.19 REMARK 500 10 PHE A 419 70.90 70.84 REMARK 500 10 ASP A 423 -162.56 -77.27 REMARK 500 11 ASP A 416 -169.45 -74.94 REMARK 500 11 ASP A 423 -171.75 -64.81 REMARK 500 REMARK 500 REMARK: NULL DBREF 1FGD A 409 426 UNP P07204 TRBM_HUMAN 427 444 SEQRES 1 A 18 CYS PRO GLU GLY TYR ILE LEU ASP ASP GLY PHE ILE CYS SEQRES 2 A 18 THR ASP ILE ASP GLU SHEET 1 A 2 LEU A 415 ASP A 416 0 SHEET 2 A 2 ILE A 420 CYS A 421 -1 O ILE A 420 N ASP A 416 SSBOND 1 CYS A 409 CYS A 421 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000